My Quote Request
No products added yet
6505-01-174-1471
20 Products
NDC00044-1021-02
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011741471
NSN
6505-01-174-1471
NDC00044-1021-02
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011741471
NSN
6505-01-174-1471
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS HYDROMORPHONE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
H714
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011738229
NSN
6505-01-173-8229
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 18.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: ONE 2 ML PARTIAL FILL CARTRIDGE-NEEDLE UNIT CONTAINING 1 ML HEPARIN SODIUM AND TWO 2 ML CARTRIDGE-NEEDLE UNITS CONTAINING SODIUM CHLORIDE INJECTIONWRAPPED TOGETHER IN A SINGLE PACKAGE
PRIMARY CONTAINER TYPE: 3 CARTRIDGE-NEEDLE UNITS
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: NEEDLE SIZE 25 GAGE BY 5/8 INCH
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
HEP-PAK
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011738229
NSN
6505-01-173-8229
HEP-PAK
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011738229
NSN
6505-01-173-8229
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 18.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: ONE 2 ML PARTIAL FILL CARTRIDGE-NEEDLE UNIT CONTAINING 1 ML HEPARIN SODIUM AND TWO 2 ML CARTRIDGE-NEEDLE UNITS CONTAINING SODIUM CHLORIDE INJECTIONWRAPPED TOGETHER IN A SINGLE PACKAGE
PRIMARY CONTAINER TYPE: 3 CARTRIDGE-NEEDLE UNITS
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: NEEDLE SIZE 25 GAGE BY 5/8 INCH
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
NDC00024-0725-03
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011738229
NSN
6505-01-173-8229
NDC00024-0725-03
HEPARIN LOCK FLUSH SOLUTION,USP
NSN, MFG P/N
6505011738229
NSN
6505-01-173-8229
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 18.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: ONE 2 ML PARTIAL FILL CARTRIDGE-NEEDLE UNIT CONTAINING 1 ML HEPARIN SODIUM AND TWO 2 ML CARTRIDGE-NEEDLE UNITS CONTAINING SODIUM CHLORIDE INJECTIONWRAPPED TOGETHER IN A SINGLE PACKAGE
PRIMARY CONTAINER TYPE: 3 CARTRIDGE-NEEDLE UNITS
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
SPECIAL FEATURES: NEEDLE SIZE 25 GAGE BY 5/8 INCH
TOTAL PRIMARY CONTAINER QUANTITY: 50
Related Searches:
ADSORBONAC
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738384
NSN
6505-01-173-8384
ADSORBONAC
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738384
NSN
6505-01-173-8384
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC00065-0505-15
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738384
NSN
6505-01-173-8384
NDC00065-0505-15
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738384
NSN
6505-01-173-8384
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
ADSORBONAC
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738385
NSN
6505-01-173-8385
ADSORBONAC
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738385
NSN
6505-01-173-8385
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC00065-0504-15
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738385
NSN
6505-01-173-8385
NDC00065-0504-15
SODIUM CHLORIDE OPHTHALMIC SOLUTION,MODIFIED
NSN, MFG P/N
6505011738385
NSN
6505-01-173-8385
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC00071-0248-24
DOCUSATE SODIUM AND CASANTHRANOL CAPSULES
NSN, MFG P/N
6505011738469
NSN
6505-01-173-8469
NDC00071-0248-24
DOCUSATE SODIUM AND CASANTHRANOL CAPSULES
NSN, MFG P/N
6505011738469
NSN
6505-01-173-8469
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS CASANTHRANOL ACTIVE INGREDIENT AND 100.000 MILLIGRAMS DOCUSATE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
3NDC50419-0112-0
THEOPHYLLINE SUSPENSION
NSN, MFG P/N
6505011738832
NSN
6505-01-173-8832
3NDC50419-0112-0
THEOPHYLLINE SUSPENSION
NSN, MFG P/N
6505011738832
NSN
6505-01-173-8832
MFG
SERTECH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS THEOPHYLLINE, ANHYDROUS PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC50458-0110-30
MEBENDAZOLE TABLETS,USP
NSN, MFG P/N
6505011738911
NSN
6505-01-173-8911
NDC50458-0110-30
MEBENDAZOLE TABLETS,USP
NSN, MFG P/N
6505011738911
NSN
6505-01-173-8911
MFG
JANSSEN PHARMACEUTICA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MEBENDAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEBENDAZOLE TABLETS USP 100 MG 36S
PRIMARY CONTAINER CONTENT QUANTITY: 36.000 TABLETS
SPECIAL FEATURES: PACKET; INDIVIDUALLY SEALED IN CHILD PROOF BLISTER PACK
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
VERMOX
MEBENDAZOLE TABLETS,USP
NSN, MFG P/N
6505011738911
NSN
6505-01-173-8911
MFG
JANSSEN PHARMACEUTICA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MEBENDAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEBENDAZOLE TABLETS USP 100 MG 36S
PRIMARY CONTAINER CONTENT QUANTITY: 36.000 TABLETS
SPECIAL FEATURES: PACKET; INDIVIDUALLY SEALED IN CHILD PROOF BLISTER PACK
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
VERMOX TABLETS
MEBENDAZOLE TABLETS,USP
NSN, MFG P/N
6505011738911
NSN
6505-01-173-8911
VERMOX TABLETS
MEBENDAZOLE TABLETS,USP
NSN, MFG P/N
6505011738911
NSN
6505-01-173-8911
MFG
JANSSEN PHARMACEUTICA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MEBENDAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEBENDAZOLE TABLETS USP 100 MG 36S
PRIMARY CONTAINER CONTENT QUANTITY: 36.000 TABLETS
SPECIAL FEATURES: PACKET; INDIVIDUALLY SEALED IN CHILD PROOF BLISTER PACK
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
Related Searches:
CEPASTAT LOZENGES
PHENOL AND MENTHOL LOZENGES
NSN, MFG P/N
6505011739675
NSN
6505-01-173-9675
CEPASTAT LOZENGES
PHENOL AND MENTHOL LOZENGES
NSN, MFG P/N
6505011739675
NSN
6505-01-173-9675
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 9.000 TROCHES
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 2 STRIP
PRIMARY CONTAINER TYPE: STRIP
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:PERCENTAGE,W/V 1.450 PHENOL ACTIVE INGREDIENT AND PERCENTAGE,W/V 0.120 MENTHOL ACTIVE INGREDIENT;
TOTAL PRIMARY CONTAINER QUANTITY: 48
TOTAL SECONDARY CONTAINER QUANTITY: 24
Related Searches:
NDC00068-0219-18
PHENOL AND MENTHOL LOZENGES
NSN, MFG P/N
6505011739675
NSN
6505-01-173-9675
NDC00068-0219-18
PHENOL AND MENTHOL LOZENGES
NSN, MFG P/N
6505011739675
NSN
6505-01-173-9675
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 9.000 TROCHES
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 2 STRIP
PRIMARY CONTAINER TYPE: STRIP
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:PERCENTAGE,W/V 1.450 PHENOL ACTIVE INGREDIENT AND PERCENTAGE,W/V 0.120 MENTHOL ACTIVE INGREDIENT;
TOTAL PRIMARY CONTAINER QUANTITY: 48
TOTAL SECONDARY CONTAINER QUANTITY: 24
Related Searches:
NDC00037-2001-03
CARISOPRODOL TABLETS,USP
NSN, MFG P/N
6505011741469
NSN
6505-01-174-1469
NDC00037-2001-03
CARISOPRODOL TABLETS,USP
NSN, MFG P/N
6505011741469
NSN
6505-01-174-1469
MFG
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS CARBOSTYRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARISOPRODOL TABLETS USP 350MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,WAMPOLE LABS
Related Searches:
NDC00364-0475-05
CARISOPRODOL TABLETS,USP
NSN, MFG P/N
6505011741469
NSN
6505-01-174-1469
NDC00364-0475-05
CARISOPRODOL TABLETS,USP
NSN, MFG P/N
6505011741469
NSN
6505-01-174-1469
MFG
SCHEIN PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS CARBOSTYRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARISOPRODOL TABLETS USP 350MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,WAMPOLE LABS
Related Searches:
SOMA 350
CARISOPRODOL TABLETS,USP
NSN, MFG P/N
6505011741469
NSN
6505-01-174-1469
MFG
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS CARBOSTYRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARISOPRODOL TABLETS USP 350MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,WAMPOLE LABS
Related Searches:
SOMA 350 TABLETS
CARISOPRODOL TABLETS,USP
NSN, MFG P/N
6505011741469
NSN
6505-01-174-1469
SOMA 350 TABLETS
CARISOPRODOL TABLETS,USP
NSN, MFG P/N
6505011741469
NSN
6505-01-174-1469
MFG
WAMPOLE LABORATORIES DIV OF CARTER-WALLACE INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 350.000 MILLIGRAMS CARBOSTYRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARISOPRODOL TABLETS USP 350MG 500S BT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,WAMPOLE LABS
Related Searches:
DILAUDID
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011741471
NSN
6505-01-174-1471
DILAUDID
HYDROMORPHONE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011741471
NSN
6505-01-174-1471
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS HYDROMORPHONE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
